Vote Now on Clinical Decisions: Genetic Testing

Posted by Karen Buckley • June 19th, 2014

A 45-year-old health conscious patient who has been with your primary care practice for several years mentions at a regular visit his three relatives with cancers of the breast, ovary, and prostate. He wants to know about genetic testing and any preventive measures he can take.

Do you think he should receive genetic screening? If so, should he be referred for whole-genome sequencing or sequencing of cancer genes only?

Read more about the patient, and arguments for each approach from two experts in the field, in the new Clinical Decisions. Then vote and comment at NEJM.org. Voting is open until July 3.

One Response to “Vote Now on Clinical Decisions: Genetic Testing”

  1. Raimundo Assis says:

    Yes, should be referred to the full genome sequencing

Leave a Reply

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

Submitting a comment indicates you have read and agreed to the Terms and Conditions.